Medical writing in the regulatory context refers to the preparation of scientific documents that summarise and critically analyse clinical and non-clinical data in support of a regulatory submission. RBridge Lifesciences provides expert medical writing services aligned with ICH CTD requirements.
What We Offer
- Clinical Overviews and Summaries (Module 2.5, 2.7)
- Non-Clinical Overviews and Summaries (Module 2.4, 2.6)
- Clinical Study Reports
- Integrated Summaries of Safety and Efficacy
- PSUR / PBRER Preparation
- Investigator's Brochures
Standards and Guidelines
- All documents prepared in accordance with ICH E3, ICH M4E, and applicable health authority guidelines
- Clinical summaries are structured to demonstrate benefit-risk balance clearly and concisely
- Non-clinical summaries align with ICH S-series guidelines
- Language is precise, objective, and free from promotional intent — in line with regulatory expectations